Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 80% Improvement Relative Risk c19hcq.org Sheshah et al. HCQ for COVID-19 LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 300 patients in Saudi Arabia Lower mortality with HCQ (p=0.001) Sheshah et al., Diabetes Research and Clinical P.., doi:10.1016/j.diabres.2020.108538 Favors HCQ Favors control
Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia
Sheshah et al., Diabetes Research and Clinical Practice, doi:10.1016/j.diabres.2020.108538
Sheshah et al., Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized.., Diabetes Research and Clinical Practice, doi:10.1016/j.diabres.2020.108538
Nov 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 300 hospitalized patients in Saudi Arabia showing HCQ adjusted odds ratio aOR 0.12, p < 0.001.
risk of death, 80.0% lower, RR 0.20, p < 0.001, treatment 267, control 33, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Sheshah et al., 13 Nov 2020, retrospective, Saudi Arabia, peer-reviewed, 8 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: diabetes research and clinical practice 172 (2021) 108538 Contents available at ScienceDirect Diabetes Research and Clinical Practice journal homepage: www.elsevier.com/locat e/dia bre s Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia Eman Sheshah a, Shaun Sabico b, Rashed M. Albakr c, Anmar A. Sultan c, Khalaf S. Alghamdi c, Khaled Al Madani d, Hadil A. Alotair e, Nasser M. Al-Daghri b,* a Diabetes Care Center, King Salman Bin Abdulaziz Hospital, Riyadh 12769, Saudi Arabia Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia c King Salman Bin Abdulaziz Hospital, Riyadh 12769, Saudi Arabia d Family Medicine Department, College of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia e Department of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia b A R T I C L E I N F O A B S T R A C T Article history: This retrospective study aimed to characterize comorbidities and associated with mortality Received 1 September 2020 among hospitalized adults with Covid-19 managed as per the Saudi Ministry of Health pro- Received in revised form tocol in a specialized tertiary hospital in Riyadh, Saudi Arabia. Medical records of 300 adult 21 October 2020 patients with PCR-confirmed SARS-CoV2 infection and admitted in King Salman Hospital Accepted 30 October 2020 (KSH) from May 1 to July 31, 2020 were included. Medical history, management and out- Available online 13 November 2020 comes were noted. Males significantly outnumber females (259 versus 41). South Asians comprise 41% of all admitted patients. Mortality rate was 10% and highest among Saudi Keywords: Type 2 Diabetes Mellitus Covid-19 Saudi Arabia South Asians males (28.9%). Type 2 diabetes mellitus (T2DM) was the most common comorbidity (45.7%). Almost all patients (99%) had pneumonia. Patients > 50 years were three times more likely to die (confidence interval, CI 1.3–6.9; p = 0.01) from Covid-19. Congestive heart failure (odds ratio OR 19.4, CI-1.5–260.0; p = 0.02) and acute kidney injury (OR 11.7, CI-4.7– 28.6; p < 0.001) were significantly associated with higher mortality. Dexamethasone use significantly improved the final outcome based on net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (p < 0.05). In this single-center study, T2DM was very common among hospitalized Covid-19 patients. Patients > 50 years, those with congestive heart failure and acute kidney injury are at higher risk for worse Covid-19 outcome. Ó 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). * Corresponding author at: Biochemistry Department, College of Science, King, Saud University, PO, Box, 2455, Riyadh 11451, Saudi Arabia. E-mail address: ndaghri@ksu.edu.sa (N.M. Al-Daghri). https://doi.org/10.1016/j.diabres.2020.108538 0168-8227/Ó 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 2 1. diabetes research and clinical practice
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit